ANTIBODIES TARGETING SARS-COV-2 AND USES THEREOF
Provided are monoclonal antibodies, or antigen-binding fragments thereof, that bind to an antigen from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), compositions comprising such antibodies and/or fragments, as well as methods of use and devices employing such antibodies and/or fragments. Further disclosed are heavy chain and light chain variable region sequences and complementarity determining regions (CDR) sequences of the antibodies..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Europäisches Patentamt - (2022) vom: 24. März Zur Gesamtaufnahme - year:2022 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
MALONIS RYAN [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2022-03-24, Last update posted on www.tib.eu: 2024-02-28, Last updated: 2024-03-08 |
---|
Patentnummer: |
WO2022026807 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA014888610 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA014888610 | ||
003 | DE-627 | ||
005 | 20240308101811.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230216s2022 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA014888610 | ||
035 | |a (EPA)WO2022026807 | ||
035 | |a (EPA)80036091 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a MALONIS RYAN |e verfasserin |4 aut | |
245 | 1 | 0 | |a ANTIBODIES TARGETING SARS-COV-2 AND USES THEREOF |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2022-03-24, Last update posted on www.tib.eu: 2024-02-28, Last updated: 2024-03-08 | ||
520 | |a Provided are monoclonal antibodies, or antigen-binding fragments thereof, that bind to an antigen from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), compositions comprising such antibodies and/or fragments, as well as methods of use and devices employing such antibodies and/or fragments. Further disclosed are heavy chain and light chain variable region sequences and complementarity determining regions (CDR) sequences of the antibodies. | ||
650 | 4 | |a bio | |
650 | 4 | |a C12P: Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a GEORGIEV GEORGE |4 aut | |
700 | 0 | |a TONG KAREN |4 aut | |
700 | 0 | |a LAI JONATHAN |4 aut | |
700 | 0 | |a CHANDRAN KARTIK |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2022) vom: 24. März |
773 | 1 | 8 | |g year:2022 |g day:24 |g month:03 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/80036091/publication/WO2022026807A1?q=WO2022026807 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
951 | |a AR | ||
952 | |j 2022 |b 24 |c 03 |